BTMD
biote Corp. NASDAQ Listed Apr 28, 2021$2.20
After hrs
$2.11
-4.09%
Mkt Cap $97.0M
52w Low $1.27
26.7% of range
52w High $4.75
50d MA $1.82
200d MA $2.60
P/E (TTM)
2.5x
EV/EBITDA
4.3x
P/B
—
Debt/Equity
-1.9x
ROE
-46.2%
P/FCF
2.7x
RSI (14)
—
ATR (14)
—
Beta
1.29
50d MA
$1.82
200d MA
$2.60
Avg Volume
244.8K
About
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet ins…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | AMC | 0.05 | 0.06 | +20.0% | 1.72 | -3.5% | -10.5% | -18.6% | -19.2% | -20.9% | -20.9% | — |
| Nov 5, 2025 | AMC | 0.05 | 0.22 | +340.0% | 2.93 | +1.7% | -3.1% | -7.5% | -16.0% | -10.9% | -9.9% | — |
| Aug 6, 2025 | AMC | 0.06 | 0.10 | +66.7% | 3.86 | -17.6% | -24.4% | -25.4% | -26.9% | -25.1% | -20.5% | — |
| May 7, 2025 | AMC | 0.06 | 0.08 | +33.3% | 3.34 | +10.5% | +12.0% | +19.8% | +19.5% | +17.1% | +18.0% | — |
| Mar 12, 2025 | AMC | 0.09 | 0.10 | +11.1% | 4.10 | -9.8% | -25.1% | -8.3% | -2.4% | -0.7% | +2.9% | — |
| Nov 12, 2024 | AMC | 0.09 | 0.33 | +266.7% | 5.52 | +6.9% | +21.7% | +19.0% | -2.4% | +11.6% | +10.3% | — |
| Aug 8, 2024 | AMC | 0.09 | 0.14 | +55.6% | 6.77 | -1.5% | -18.9% | -21.3% | -15.4% | -13.0% | -10.6% | — |
| May 7, 2024 | AMC | 0.05 | 0.23 | +360.0% | 5.77 | +1.9% | +5.2% | +8.3% | +6.1% | +4.2% | +3.1% | — |
| Mar 12, 2024 | AMC | 0.08 | 0.18 | +125.0% | 5.30 | +15.7% | +14.9% | +17.2% | +30.4% | +25.7% | +20.4% | — |
| Nov 7, 2023 | AMC | 0.08 | -0.11 | -237.5% | 5.81 | -5.3% | -23.8% | -22.5% | -22.0% | -16.7% | -14.1% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 16 | Truist | Maintains | Buy → Buy | — | $1.97 | $1.97 | +0.0% | +6.6% | +12.7% | +13.7% | +12.7% | +13.7% |
| Mar 12 | B. Riley Securities | Maintains | Neutral → Neutral | — | $1.72 | $1.66 | -3.5% | -10.5% | -18.6% | -19.2% | -20.9% | -20.9% |
| Mar 12 | TD Cowen | Maintains | Buy → Buy | — | $1.72 | $1.66 | -3.5% | -10.5% | -18.6% | -19.2% | -20.9% | -20.9% |
| Aug 7 | B. Riley Securities | Downgrade | Buy → Neutral | — | $3.86 | $3.18 | -17.6% | -24.4% | -25.4% | -26.9% | -25.1% | -20.5% |
| Mar 13 | Craig-Hallum | Maintains | Buy → Buy | — | $4.10 | $3.70 | -9.8% | -25.1% | -8.3% | -2.4% | -0.7% | +2.9% |
| Mar 13 | Roth MKM | Maintains | Buy → Buy | — | $5.30 | $6.13 | +15.7% | +14.9% | +17.2% | +30.4% | +25.7% | +20.4% |
| Jan 18 | Roth MKM | Maintains | Buy → Buy | — | $4.63 | $4.27 | -7.8% | -13.6% | -15.1% | -18.1% | -18.1% | -17.1% |
| Jan 18 | Truist | Maintains | Buy → Buy | — | $4.63 | $4.27 | -7.8% | -13.6% | -15.1% | -18.1% | -18.1% | -17.1% |
| Aug 15 | TD Cowen | Maintains | Outperform → Outperform | — | $5.41 | $5.40 | -0.1% | -5.5% | -4.3% | -8.2% | -12.5% | -8.2% |
| Aug 14 | Roth MKM | Maintains | Buy → Buy | — | $5.61 | $5.60 | -0.2% | -3.7% | -8.9% | -7.8% | -11.6% | -15.7% |
Recent Filings
8-K · 2.02
!! High
biote Corp. -- 8-K 2.02: Earnings Results
biote Corp. reported Q1 2026 financial results, with the company meeting earnings expectations and maintaining operational momentum during the first quarter.
May 6
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
BTMD disclosed forward-looking statements about future revenue projections via Regulation FD, signaling management confidence in growth but creating legal risk if guidance isn't achieved.
Apr 3
8-K
Unknown — 8-K Filing
BTMD's 2025 revenue grew to $192.2M with strong 71.5% gross margins and $31.6M net income, demonstrating profitable scaling that should attract value investors seeking biotech companies with sustainable earnings growth.
Mar 11
Data updated apr 24, 2026 11:06pm
· Source: massive.com